Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K S Zier

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Experimental and Clinical Immunogenetics|January 1, 1985
Proliferative T cell clones directed at a human minor antigenK S Zier
Journal of Immunological Methods|November 28, 1985
Generation of antigen specific cytotoxic T lymphocytes (CTL) directed against class II molecules expressed by activated T cellsK S Zier
Cellular Immunology|July 1, 1986
Expression of class II antigens by subsets of activated T cellsK S Zier
Human Immunology|April 1, 1982
Functional and antigenic properties of cultured T cells in the cell mediated lympholysis (CML) assayK S Zier
Cancer Immunology, Immunotherapy : CII|September 9, 1999
Generation of anti-allogeneic cytotoxic T lymphocytes depends upon a signal, not delivered by tumor cells, that can be provided in trans in the presence of exogenous interleukin-2K S Zier, S Salvadori
Journal of Molecular Medicine (Berlin, Germany)|March 1, 1996
IL-2 gene therapy of solid tumors: an approach for the prevention of signal transduction defects in T cellsK S Zier, B Gansbacher
European Journal of Cancer (Oxford, England : 1990)|July 1, 1996
Tumour cell vaccines that secrete interleukin-2 (IL-2) and interferon gamma (IFN gamma) are recognised by T cells while resisting destruction by natural killer (NK) cellsK S Zier, B Gansbacher
Human Immunology|August 1, 1981
Generation of discriminatory PL against HLA-D antigens not detected by serologyK S Zier, B Gansbacher
Human Gene Therapy|October 1, 1995
The impact of gene therapy on T cell function in cancerK S Zier, B Gansbacher
Clinical and Experimental Immunology|June 1, 1989
HLA class II mRNA accumulation by activated human T cells following growth in conditioned mediumB Gansbacher, K S Zier
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Experimental and Clinical Immunogenetics|January 1, 1985
Proliferative T cell clones directed at a human minor antigenK S Zier
Journal of Immunological Methods|November 28, 1985
Generation of antigen specific cytotoxic T lymphocytes (CTL) directed against class II molecules expressed by activated T cellsK S Zier
Cellular Immunology|July 1, 1986
Expression of class II antigens by subsets of activated T cellsK S Zier
Human Immunology|April 1, 1982
Functional and antigenic properties of cultured T cells in the cell mediated lympholysis (CML) assayK S Zier
Cancer Immunology, Immunotherapy : CII|September 9, 1999
Generation of anti-allogeneic cytotoxic T lymphocytes depends upon a signal, not delivered by tumor cells, that can be provided in trans in the presence of exogenous interleukin-2K S Zier, S Salvadori
Journal of Molecular Medicine (Berlin, Germany)|March 1, 1996
IL-2 gene therapy of solid tumors: an approach for the prevention of signal transduction defects in T cellsK S Zier, B Gansbacher
European Journal of Cancer (Oxford, England : 1990)|July 1, 1996
Tumour cell vaccines that secrete interleukin-2 (IL-2) and interferon gamma (IFN gamma) are recognised by T cells while resisting destruction by natural killer (NK) cellsK S Zier, B Gansbacher
Human Immunology|August 1, 1981
Generation of discriminatory PL against HLA-D antigens not detected by serologyK S Zier, B Gansbacher
Human Gene Therapy|October 1, 1995
The impact of gene therapy on T cell function in cancerK S Zier, B Gansbacher
Clinical and Experimental Immunology|June 1, 1989
HLA class II mRNA accumulation by activated human T cells following growth in conditioned mediumB Gansbacher, K S Zier
Pageof 5